Posted on
Beijing has introduced Sunday that may restrict authorities purchases of medical gadgets from the EU evaluated in over 45 million yuan (about 5.3 million euros) as a direct response to the European Commission determination to restrict the entry of Chinese corporations to the general public contract market market.
Based on the earlier transfer of the Commission final month, Chinese corporations are prohibited to supply public contracts for medical gadgets within the EU single market by exceeding 5 million euros. In addition, the successful affords should not comprise greater than 50% of the elements from China.
In a declaration, China mentioned she had “different alternative than implementing countermeasures”.
A spokesman for the Chinese Ministry of Commerce added that Beijing has repeatedly expressed, by bilateral dialogues, his will to face the variations with the EU by dialogue, session and bilateral contract agreements.
“Unfortunately, the EU has ignored the goodwill and sincerity of China and continues to impose restrictive measures and construct new protectionist boundaries”, reads the declaration.
The latter escalation follows Beijing’s announcement final week of anti -dumping duties as much as 34.9% on the European imports of the brandy for the following 5 years.
The mannequin of mutual industrial actions continues to outline the EU-China financial relationship.
In latest weeks, China has prolonged its anti-dumping investigations on the EU-month-old pork imports of pork, whereas the EU has imposed charges as much as 45% on Chinese electrical autos (EV).
These developments happen in a big second in EU-China relationships, that are present process a cautious diplomatic reset.
A key milestone within the evolution dialogue would be the subsequent EU-CLINE SUCTICE, which is able to happen in Beijing within the second half of July 2025.
Concerns from Europe
Medtech Europe, the EU medical gadgets business affiliation, expressed remorse for China’s newest determination, stating that additional limits the entry to the Chinese public procurement market.
“The measures of this threat threat deepening industrial tensions and ultimately they deny sufferers well timed entry to indispensable medical applied sciences,” mentioned the group in a observe.
“We urge each the European Union and China to have interaction in a constructive dialogue to resolve the present challenges to entry to the market and help the equal, predictable and mutual negotiation circumstances”.
The European Chamber of Commerce in China has echoed these considerations, warning that the announcement will increase uncertainty for European corporations working within the nation.
In specific, the dearth of specificity within the new restrictions will increase the danger that the native authorities that handle public affords can implement measures in an excessively rigorous manner.
This may additionally exclude producers of European medical gadgets extremely positioned by affords for contracts, in response to the Chamber.
For instance, though the Chinese authorities has indicated that European corporations invested in China shall be exempt from restrictions, the discover doesn’t make clear what qualifies as a “European firm”.
According to the European Chamber, additionally it is not clear whether or not the availability affords primarily based on the amount, which frequently exceed the edge, fall inside the new guidelines.
